Robert Buckley Sells 1,830 Shares of Novanta Inc. (NASDAQ:NOVT) Stock

Novanta Inc. (NASDAQ:NOVT) CFO Robert Buckley sold 1,830 shares of the stock in a transaction that occurred on Tuesday, July 16th. The shares were sold at an average price of $180.18, for a total value of $329,729.40. Following the completion of the sale, the chief financial officer now directly owns 120,419 shares of the company’s stock, valued at $21,697,095.42. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Robert Buckley also recently made the following trade(s):

• On Friday, July 12th, Robert Buckley sold 1,830 shares of Novanta stock. The shares were sold at an average price of $170.19, for a total transaction of $311,447.70.
• On Monday, July 1st, Robert Buckley sold 1,830 shares of Novanta stock. The stock was sold at an average price of $161.09, for a total transaction of $294,794.70.

Novanta Price Performance

Shares of NOVT opened at $172.49 on Friday. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.77 and a current ratio of 2.83. Novanta Inc. has a fifty-two week low of $111.20 and a fifty-two week high of $187.12. The firm has a 50-day simple moving average of $164.49 and a 200-day simple moving average of $163.58. The company has a market capitalization of $6.19 billion, a price-to-earnings ratio of 89.37 and a beta of 1.31.

Novanta (NASDAQ:NOVT) last posted its quarterly earnings data on Tuesday, May 7th. The technology company reported $0.74 earnings per share for the quarter, topping analysts’ consensus estimates of $0.57 by $0.17. The company had revenue of $230.92 million during the quarter, compared to analysts’ expectations of $227.85 million. Novanta had a return on equity of 16.58% and a net margin of 7.76%. The firm’s revenue for the quarter was up 5.4% on a year-over-year basis. During the same period last year, the firm earned $0.74 EPS. On average, equities research analysts anticipate that Novanta Inc. will post 3.26 earnings per share for the current year.

Hedge Funds Weigh In On Novanta

Institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in shares of Novanta by 0.6% in the third quarter. Vanguard Group Inc. now owns 3,766,008 shares of the technology company’s stock valued at $540,196,000 after acquiring an additional 22,294 shares in the last quarter. Diversified Trust Co raised its stake in shares of Novanta by 38.7% during the 4th quarter. Diversified Trust Co now owns 3,613 shares of the technology company’s stock worth $608,000 after buying an additional 1,009 shares in the last quarter. Baker Tilly Wealth Management LLC acquired a new stake in shares of Novanta in the 4th quarter valued at approximately $311,000. OneAscent Financial Services LLC purchased a new stake in shares of Novanta in the fourth quarter valued at approximately $206,000. Finally, Revolve Wealth Partners LLC acquired a new position in Novanta during the fourth quarter worth $206,000. 98.35% of the stock is owned by institutional investors and hedge funds.

Novanta Company Profile

Novanta Inc, together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. The company operates through three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation.